Revvity | PKI - 流动负债

股票价格
86.77
每天变化
-0.38 -0.44%
每月一次
-1.22%
每年
-7.98%
Q2 预测
91.89


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.68B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


流动负债 更改 日
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Bio Techne USD 140.43M 4.12M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Celltrion KRW 4.01T 343.96B 2025-09
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.34B 62M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Edwards Lifesciences USD 1.81B 225.7M 2025-12
Illumina USD 1.59B 377M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
IQVIA Holdings USD 8.34B 170M 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Mesa Laboratories USD 54.4M 6.1M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
OraSure Technologies USD 39.8M 453K 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pacific Biosciences Of California USD 72.83M 9.62M 2025-12
Pharma Mar EUR 93.88M 4.94M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Quidel USD 966.1M 198.2M 2025-12
Repligen USD 135.83M 4.69M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Waters USD 1.24B 11.8M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09